{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:06:16Z","timestamp":1773875176714,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The BRAF gene is frequently mutated in cancer. The most common genetic mutation is a single nucleotide transition which gives rise to a constitutively active BRAF kinase (BRAF<jats:sup>V600E<\/jats:sup>) which in turn sustains continuous cell proliferation. The study of BRAF<jats:sup>V600E<\/jats:sup> murine models has been mainly focused on the role of BRAF<jats:sup>V600E<\/jats:sup> in tumor development but little is known on the early molecular impact of BRAF<jats:sup>V600E<\/jats:sup> expression in vivo. Here, we study the immediate effects of acute ubiquitous BRAF<jats:sup>V600E<\/jats:sup> activation in vivo. We find that BRAF<jats:sup>V600E<\/jats:sup> elicits a rapid DNA damage response in the liver, spleen, lungs but not in thyroids. This DNA damage response does not occur at telomeres and is accompanied by activation of the senescence marker p21<jats:sup>CIP1<\/jats:sup> only in lungs but not in liver or spleen. Moreover, in lungs, BRAF<jats:sup>V600E<\/jats:sup> provokes an acute inflammatory state with a tissue-specific recruitment of neutrophils in the alveolar parenchyma and macrophages in bronchi\/bronchioles, as well as bronchial\/bronchiolar epithelium transdifferentiation and development of adenomas. Furthermore, whereas in non-tumor alveolar type II (ATIIs) pneumocytes, acute BRAF<jats:sup>V600E<\/jats:sup> induction elicits rapid p53-independent p21<jats:sup>CIP1<\/jats:sup> activation, adenoma ATIIs express p53 without resulting in p21<jats:sup>CIP1<\/jats:sup> gene activation. Conversely, albeit in Club cells BRAF<jats:sup>V600E<\/jats:sup>-mediated proliferative cue is more exacerbated compared to that occurring in ATIIs, such oncogenic stimulus culminates with p21<jats:sup>CIP1<\/jats:sup>-mediated cell cycle arrest and apoptosis. Our findings indicate that acute BRAF<jats:sup>V600E<\/jats:sup> expression drives an immediate induction of DNA damage response in vivo. More importantly, it also results in rapid differential responses of cell cycle and senescence-associated proteins in lung epithelia, thus revealing the early molecular changes emerging in BRAF<jats:sup>V600E<\/jats:sup>-challenged cells during tumorigenesis in vivo.<\/jats:p>","DOI":"10.1038\/s41419-022-04597-z","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T09:02:55Z","timestamp":1644483775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Early differential responses elicited by BRAFV600E in adult mouse models"],"prefix":"10.1038","volume":"13","author":[{"given":"Giuseppe","family":"Bosso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Lanuza-Gracia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Pi\u00f1eiro-Hermida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merve","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4211-233X","authenticated-orcid":false,"given":"Maria A.","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"4597_CR1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2011-08-368209","volume":"119","author":"L Arcaini","year":"2012","unstructured":"Arcaini L, Zibellini S, Boveri E, Riboni R, Rattotti S, Varettoni M, et al. The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms. Blood 2012;119:188.","journal-title":"Blood"},{"key":"4597_CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1677\/ERC-07-0212","volume":"15","author":"F Frasca","year":"2008","unstructured":"Frasca F, Nucera C, Pellegriti G, Gangemi P, Attard M, Stella M, et al. BRAF(V600E) mutation and the biology of papillary thyroid cancer. Endocr Relat Cancer. 2008;15:191.","journal-title":"Endocr Relat Cancer"},{"key":"4597_CR3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ygyno.2016.08.320","volume":"143","author":"A Kaldawy","year":"2016","unstructured":"Kaldawy A, Segev Y, Lavie O, Auslender R, Sopik V, Narod SA. Low-grade serous ovarian cancer: a review. Gynecol Oncol. 2016;143:433.","journal-title":"Gynecol Oncol"},{"key":"4597_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1758835919856494","volume":"11","author":"M Ducreux","year":"2019","unstructured":"Ducreux M, Chamseddine A, Laurent-Puig P, Smolenschi C, Hollebecque A, Dartigues P, et al. Molecular targeted therapy of BRAF-mutant colorectal cancer. Ther Adv Med Oncol. 2019;11:1\u201315.","journal-title":"Ther Adv Med Oncol"},{"key":"4597_CR5","first-page":"212566","volume":"8","author":"JG Bustamante Alvarez","year":"2019","unstructured":"Bustamante Alvarez JG, Otterson GA. Agents to treat BRAF-mutant lung cancer. Drugs Context. 2019;8:212566.","journal-title":"Drugs Context"},{"key":"4597_CR6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm3979","volume":"16","author":"H Lavoie","year":"2015","unstructured":"Lavoie H, Therrien M. Regulation of RAF protein kinases in ERK signalling. Nat Rev Mol Cell Biol. 2015;16:281.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4597_CR7","volume":"10","author":"PA Ascierto","year":"2012","unstructured":"Ascierto PA, Kirkwood JM, Grob JJ, Simeone E, Grimaldi AM, Maio M, et al. The role of BRAF V600 mutation in melanoma. J Transl Med. 2012;10:85.","journal-title":"J Transl Med"},{"key":"4597_CR8","doi-asserted-by":"crossref","first-page":"11493","DOI":"10.1158\/0008-5472.CAN-05-2211","volume":"65","author":"K Mercer","year":"2005","unstructured":"Mercer K, Giblett S, Green S, Lloyd D, Dias SDR, Plumb M, et al. Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts. Cancer Res. 2005;65:11493.","journal-title":"Cancer Res"},{"key":"4597_CR9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1101\/gad.1516407","volume":"21","author":"D Dankort","year":"2007","unstructured":"Dankort D, Filenova E, Collado M, Serrano M, Jones K, McMahon M. A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev. 2007;21:379.","journal-title":"Genes Dev"},{"key":"4597_CR10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ng.356","volume":"41","author":"D Dankort","year":"2009","unstructured":"Dankort D, Curley DP, Cartlidge RA, Nelson B, Karnezis AN, Damsky WE, et al. BrafV600E cooperates with Pten loss to induce metastatic melanoma. Nat Genet. 2009;41:544.","journal-title":"Nat Genet"},{"key":"4597_CR11","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ccr.2009.02.022","volume":"15","author":"N Dhomen","year":"2009","unstructured":"Dhomen N, Reis-Filho JS, da Rocha Dias S, Hayward R, Savage K, Delmas V, et al. Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell. 2009;15:294.","journal-title":"Cancer Cell"},{"key":"4597_CR12","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1158\/0008-5472.CAN-10-4463","volume":"71","author":"RP Charles","year":"2011","unstructured":"Charles RP, Iezza G, Amendola E, Dankort D, McMahon M. Mutationally activated BRAFV600E elicits papillary thyroid cancer in the adult mouse. Cancer Res. 2011;71:3863.","journal-title":"Cancer Res"},{"key":"4597_CR13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/mc.22510","volume":"56","author":"M Yamamoto","year":"2017","unstructured":"Yamamoto M, Tanaka H, Xin B, Nishikawa Y, Yamazaki K, Shimizu K, et al. Role of the BrafV637E mutation in hepatocarcinogenesis induced by treatment with diethylnitrosamine in neonatal B6C3F1 mice. Mol Carcinog. 2017;56:478.","journal-title":"Mol Carcinog"},{"key":"4597_CR14","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1158\/0008-5472.CAN-12-0820","volume":"72","author":"J Wang","year":"2012","unstructured":"Wang J, Kobayashi T, Floc\u2019h N, Kinkade CW, Aytes A, Dankort D, et al. B-raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancer. Cancer Res. 2012;72:4765.","journal-title":"Cancer Res"},{"key":"4597_CR15","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/emmm.201000099","volume":"2","author":"LAS Carragher","year":"2010","unstructured":"Carragher LAS, Snell KR, Giblett SM, Aldridge VSS, Patel B, Cook SJ, et al. V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol Med. 2010;2:458.","journal-title":"EMBO Mol Med"},{"key":"4597_CR16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/biom10030420","volume":"10","author":"M Mijit","year":"2020","unstructured":"Mijit M, Caracciolo V, Melillo A, Amicarelli F, Giordano A. Role of p53 in the regulation of cellular senescence. Biomolecules 2020;10:420.","journal-title":"Biomolecules"},{"key":"4597_CR17","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.15252\/emmm.201404838","volume":"7","author":"T Kamata","year":"2015","unstructured":"Kamata T, Jin H, Giblett S, Patel B, Patel F, Foster C, et al. The cholesterol-binding protein NPC 2 restrains recruitment of stromal macrophage-lineage cells to early-stage lung tumours. EMBO Mol Med. 2015;7:1119.","journal-title":"EMBO Mol Med"},{"key":"4597_CR18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.stem.2007.03.002","volume":"1","author":"Y Ruzankina","year":"2007","unstructured":"Ruzankina Y, Pinzon-Guzman C, Asare A, Ong T, Pontano L, Cotsarelis G, et al. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell. 2007;1:113.","journal-title":"Cell Stem Cell"},{"key":"4597_CR19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/01926230600867750","volume":"34","author":"AW Suttie","year":"2006","unstructured":"Suttie AW. Histopathology of the spleen. Toxicol Pathol. 2006;34:466.","journal-title":"Toxicol Pathol"},{"key":"4597_CR20","doi-asserted-by":"crossref","first-page":"11386","DOI":"10.18632\/aging.103186","volume":"12","author":"Z Wang","year":"2020","unstructured":"Wang Z, Lin Y, Jin S, Wei T, Zheng Z, Chen W. Bone marrow mesenchymal stem cells improve thymus and spleen function of aging rats through affecting P21\/PCNA and suppressing oxidative stress. Aging (Albany NY). 2020;12:11386.","journal-title":"Aging (Albany NY)"},{"key":"4597_CR21","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1038\/onc.2017.235","volume":"36","author":"S Garnett","year":"2017","unstructured":"Garnett S, Dutchak KL, McDonough RV, Dankort D. P53 loss does not permit escape from Braf V600E -induced senescence in a mouse model of lung cancer. Oncogene. 2017;36:6325\u201335.","journal-title":"Oncogene"},{"key":"4597_CR22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","volume":"9","author":"T Abbas","year":"2009","unstructured":"Abbas T, Dutta A. P21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9:400.","journal-title":"Nat Rev Cancer"},{"key":"4597_CR23","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1128\/MCB.17.9.5598","volume":"17","author":"D Woods","year":"1997","unstructured":"Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol. 1997;17:5598\u2013611.","journal-title":"Mol Cell Biol"},{"key":"4597_CR24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2174\/156800910793357943","volume":"10","author":"M Grusch","year":"2010","unstructured":"Grusch M, Petz M, Metzner T, Ozturk D, Schneller D, Mikulits W. The crosstalk of RAS with the TGF-\u03b2 family during carcinoma progression and its implications for targeted cancer therapy. Curr Cancer Drug Targets. 2010;10:849\u201357.","journal-title":"Curr Cancer Drug Targets"},{"key":"4597_CR25","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1038\/sj.onc.1208928","volume":"24","author":"D Javelaud","year":"2005","unstructured":"Javelaud D, Mauviel A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-\u03b2: Implications for carcinogenesis. Oncogene. 2005;24:5742\u201350.","journal-title":"Oncogene"},{"key":"4597_CR26","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/onc.2013.45","volume":"33","author":"TM Becker","year":"2014","unstructured":"Becker TM, Boyd SC, Mijatov B, Gowrishankar K, Snoyman S, Pupo GM, et al. Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor. Oncogene. 2014;33:1158\u201366.","journal-title":"Oncogene"},{"key":"4597_CR27","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2013.32","volume":"133","author":"F Liu","year":"2013","unstructured":"Liu F, Cao J, Wu J, Sullivan K, Shen J, Ryu B, et al. Stat3-targeted therapies overcome the acquired resistance to vemurafenib in melanomas. J Invest Dermatol. 2013;133:2041\u20139.","journal-title":"J Invest Dermatol"},{"key":"4597_CR28","doi-asserted-by":"crossref","first-page":"29244","DOI":"10.1074\/jbc.M909467199","volume":"275","author":"K Pardali","year":"2000","unstructured":"Pardali K, Kurisaki A, Mor\u00e9n A, Ten Dijke P, Kardassis D, Moustakas A. Role of Smad proteins and transcription factor Sp1 in p21Waf1\/Cip1 regulation by transforming growth factor-\u03b2. J Biol Chem. 2000;275:29244\u201356.","journal-title":"J Biol Chem"},{"key":"4597_CR29","first-page":"14","volume":"67","author":"V Hawthorne","year":"2007","unstructured":"Hawthorne V, Tseng L-M, Yu D. Transcriptional upregulation of the p21Cip1 promoter by STAT3 and nuclear ErbB2. Cancer Res. 2007;67:14\u201318.","journal-title":"Cancer Res."},{"key":"4597_CR30","doi-asserted-by":"crossref","first-page":"e29093","DOI":"10.1371\/journal.pone.0029093","volume":"6","author":"E Zanucco","year":"2011","unstructured":"Zanucco E, G\u00f6tz R, Potapenko T, Carraretto I, Ceteci S, Ceteci F, et al. Expression of B-RAF V600E in type II pneumocytes causes abnormalities in alveolar formation, airspace enlargement and tumor formation in mice. PLoS ONE. 2011;6:e29093.","journal-title":"PLoS ONE"},{"key":"4597_CR31","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1038\/onc.2016.500","volume":"36","author":"DR Principe","year":"2017","unstructured":"Principe DR, DIaz AM, Torres C, Mangan RJ, DeCant B, McKinney R, et al. TGF\u03b2 engages MEK\/ERK to differentially regulate benign and malignant pancreas cell function. Oncogene 2017;36:4336\u201348.","journal-title":"Oncogene"},{"key":"4597_CR32","first-page":"1","volume":"6","author":"M Sen","year":"2017","unstructured":"Sen M, Akeno N, Reece A, Miller AL, Simpson DS, Wikenheiser-Brokamp KA. P16 controls epithelial cell growth and suppresses carcinogenesis through mechanisms that do not require RB1 function. Oncogenesis. 2017;6:1\u201312.","journal-title":"Oncogenesis"},{"key":"4597_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.00001","volume":"9","author":"H Li","year":"2018","unstructured":"Li H, Jiang T, Li MQ, Zheng XL, Zhao GJ. Transcriptional regulation of macrophages polarization by microRNAs. Front Immunol. 2018;9:1\u201312.","journal-title":"Front Immunol"},{"key":"4597_CR34","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00262-017-2052-5","volume":"66","author":"XL Fu","year":"2017","unstructured":"Fu XL, Duan W, Su CY, Mao FY, Lv YP, Teng YS, et al. Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progression. Cancer Immunol Immunother. 2017;66:1597\u2013608.","journal-title":"Cancer Immunol Immunother"},{"key":"4597_CR35","first-page":"1","volume":"5","author":"N Wang","year":"2014","unstructured":"Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage M1-M2 polarization balance. Front Immunol. 2014;5:1\u20139.","journal-title":"Front Immunol"},{"key":"4597_CR36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cmet.2007.06.010","volume":"6","author":"MA Bouhlel","year":"2007","unstructured":"Bouhlel MA, Derudas B, Rigamonti E, Di\u00e8vart R, Brozek J, Haulon S, et al. PPAR\u03b3 activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 2007;6:137\u201343.","journal-title":"Cell Metab"},{"key":"4597_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.00001","volume":"10","author":"Y Tian","year":"2019","unstructured":"Tian Y, Yang C, Yao Q, Qian L, Liu J, Xie X, et al. Procyanidin B2 activates PPAR\u03b3 to induce M2 polarization in mouse macrophages. Front Immunol. 2019;10:1\u201312.","journal-title":"Front Immunol"},{"key":"4597_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/2162402X.2016.1151991","volume":"5","author":"OM Pello","year":"2016","unstructured":"Pello OM. Macrophages and c-Myc cross paths. Oncoimmunology 2016;5:1\u20132.","journal-title":"Oncoimmunology"},{"key":"4597_CR39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1371\/journal.pone.0145342","volume":"10","author":"KA Jablonski","year":"2015","unstructured":"Jablonski KA, Amici SA, Webb LM, Ruiz-Rosado JDD, Popovich PG, Partida-Sanchez S, et al. Novel markers to delineate murine M1 and M2 macrophages. PLoS ONE. 2015;10:5\u201311.","journal-title":"PLoS ONE"},{"key":"4597_CR40","doi-asserted-by":"publisher","first-page":"8841911","DOI":"10.1155\/2021\/8841911","volume":"2021","author":"E Ferraro","year":"2021","unstructured":"Ferraro E, German\u00f2 M, Mollace R, Mollace V, Malara N. HIF-1, the Warburg effect, and macrophage\/microglia polarization potential role in COVID-19 pathogenesis. Oxid Med Cell Longev. 2021;2021:8841911. https:\/\/doi.org\/10.1155\/2021\/8841911.","journal-title":"Oxid Med Cell Longev"},{"key":"4597_CR41","first-page":"9029327","volume":"2017","author":"T Wang","year":"2017","unstructured":"Wang T, Liu H, Lian G, Zhang S, Wang X, Jiang C. HIF1 \u03b1-induced glycolysis metabolism is essential to the activation of inflammatory macrophages. Mediators Inflamm. 2017;2017:9029327.","journal-title":"Mediators Inflamm"},{"key":"4597_CR42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1101\/gad.1881410","volume":"24","author":"N Takeda","year":"2010","unstructured":"Takeda N, Dea ELO, Doedens A, Kim J, Weidemann A, Stockmann C, et al. Differential activation and antagonistic function of HIF- a isoforms in macrophages are essential for NO homeostasis. Genes Dev. 2010;24:491\u2013501.","journal-title":"Genes Dev"},{"key":"4597_CR43","doi-asserted-by":"crossref","unstructured":"Liou G and Storz P Clinic M HHS Public Access. 2016;97\u2013104.","DOI":"10.1007\/978-1-4939-2522-3_7"},{"key":"4597_CR44","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.bbamem.2012.02.002","volume":"1818","author":"A Reis","year":"2012","unstructured":"Reis A, Spickett CM. Chemistry of phospholipid oxidation. Biochim Biophys Acta Biomembr. 2012;1818:2374\u201387.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"4597_CR45","doi-asserted-by":"crossref","first-page":"C537","DOI":"10.1152\/ajpcell.00101.2016","volume":"311","author":"M Breitzig","year":"2016","unstructured":"Breitzig M, Bhimineni C, Lockey R, Kolliputi N. 4-Hydroxy-2-nonenal: a critical target in oxidative stress? Am J Physiol -Cell Physiol. 2016;311:C537\u201343.","journal-title":"Am J Physiol -Cell Physiol"},{"key":"4597_CR46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.redox.2014.12.011","volume":"4","author":"H Zhong","year":"2015","unstructured":"Zhong H, Yin H. Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: focusing on mitochondria. Redox Biol. 2015;4:193\u20139.","journal-title":"Redox Biol"},{"key":"4597_CR47","doi-asserted-by":"crossref","first-page":"9697","DOI":"10.1073\/pnas.86.24.9697","volume":"86","author":"MK Shigenaga","year":"1989","unstructured":"Shigenaga MK, Gimeno CJ, Ames BN. Urinary 8-hydroxy-2\u2019-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA. 1989;86:9697\u2013701.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4597_CR48","first-page":"120","volume":"27","author":"A Valavanidis","year":"2009","unstructured":"Valavanidis A, Vlachogianni T, Fiotakis C. 8-Hydroxy-2\u2032 -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Heal - Part C Environ Carcinog Ecotoxicol Rev. 2009;27:120\u201339.","journal-title":"J Environ Sci Heal - Part C Environ Carcinog Ecotoxicol Rev"},{"key":"4597_CR49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0076-6879(00)19016-0","volume":"319","author":"J Cadet","year":"2000","unstructured":"Cadet J, Douki T, Pouget JP, Ravanat JL. Singlet oxygen DNA damage products: formation and measurement. Methods Enzymol. 2000;319:143\u201353.","journal-title":"Methods Enzymol"},{"key":"4597_CR50","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/sj.eye.6702064","volume":"20","author":"HC Kau","year":"2006","unstructured":"Kau HC, Tsai CC, Lee CF, Kao SC, Hsu WM, Liu JH, et al. Increased oxidative DNA damage, 8-hydroxydeoxy-guanosine, in human pterygium. Eye. 2006;20:826\u201331.","journal-title":"Eye"},{"key":"4597_CR51","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.ajpath.2011.11.026","volume":"180","author":"JJC Sheu","year":"2012","unstructured":"Sheu JJC, Guan B, Tsai FJ, Hsiao EYT, Chen CM, Seruca R, et al. Mutant BRAF induces DNA strand breaks, activates DNA damage response pathway, and up-regulates glucose transporter-1 in nontransformed epithelial cells. Am J Pathol. 2012;180:1179.","journal-title":"Am J Pathol"},{"key":"4597_CR52","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/embor.2010.160","volume":"11","author":"H Gehart","year":"2010","unstructured":"Gehart H, Kumpf S, Ittner A, Ricci R. MAPK signalling in cellular metabolism: stress or wellness? EMBO Rep. 2010;11:834.","journal-title":"EMBO Rep."},{"key":"4597_CR53","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1038\/emboj.2012.132","volume":"31","author":"A Suram","year":"2012","unstructured":"Suram A, Kaplunov J, Patel PL, Ruan H, Cerutti A, Boccardi V, et al. Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions. EMBO J. 2012;31:2839.","journal-title":"EMBO J"},{"key":"4597_CR54","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molmed.2017.02.001","volume":"23","author":"AG Georgakilas","year":"2017","unstructured":"Georgakilas AG, Martin OA, Bonner WM. p21: a two-faced genome guardian. Trends Mol Med. 2017;23:310.","journal-title":"Trends Mol Med"},{"key":"4597_CR55","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41388-019-1022-0","volume":"39","author":"T Ko","year":"2020","unstructured":"Ko T, Sharma R, Li S. Genome-wide screening identifies novel genes implicated in cellular sensitivity to BRAFV600E expression. Oncogene 2020;39:723.","journal-title":"Oncogene"},{"key":"4597_CR56","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1101\/gad.12.19.2997","volume":"12","author":"J Zhu","year":"1998","unstructured":"Zhu J, Woods D, McMahon M, Bishop JM. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 1998;12:2997.","journal-title":"Genes Dev"},{"key":"4597_CR57","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1158\/0008-5472.CAN-14-3701","volume":"75","author":"A Shai","year":"2015","unstructured":"Shai A, Dankort D, Juan J, Green S, McMahon M. TP53 silencing bypasses growth arrest of BRAFV600E-induced lung tumor cells in a two-switch model of lung tumorigenesis. Cancer Res. 2015;75:3167\u201380.","journal-title":"Cancer Res"},{"key":"4597_CR58","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.celrep.2017.01.069","volume":"18","author":"M Cicchini","year":"2017","unstructured":"Cicchini M, Buza EL, Sagal KM, Gudiel AA, Durham AC, Feldser DM. Context-dependent effects of amplified MAPK signaling during lung adenocarcinoma initiation and progression. Cell Rep. 2017;18:1958\u201369.","journal-title":"Cell Rep."},{"key":"4597_CR59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature23297","volume":"548","author":"P Nieto","year":"2017","unstructured":"Nieto P, Ambrogio C, Esteban-Burgos L, G\u00f3mez-L\u00f3pez G, Blasco MT, Yao Z, et al. A Braf kinase-inactive mutant induces lung adenocarcinoma. Nature 2017;548:239.","journal-title":"Nature"},{"key":"4597_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1083\/jcb.202002120","volume":"219","author":"S Pi\u00f1eiro-Hermida","year":"2020","unstructured":"Pi\u00f1eiro-Hermida S, Autilio C, Mart\u00ednez P, Bosch F, P\u00e9rez-Gil J, Blasco MA. Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging. J Cell Biol. 2020;219:1\u201321.","journal-title":"J Cell Biol"},{"key":"4597_CR61","doi-asserted-by":"crossref","first-page":"e1009410","DOI":"10.1371\/journal.pgen.1009410","volume":"17","author":"R S\u00e1nchez-V\u00e1zquez","year":"2021","unstructured":"S\u00e1nchez-V\u00e1zquez R, Mart\u00ednez P, Blasco MA. AKT-dependent signaling of extracellular cues through telomeres impact on tumorigenesis. PLoS Genet. 2021;17:e1009410.","journal-title":"PLoS Genet"},{"key":"4597_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/emmm.201910292","volume":"11","author":"L Bejarano","year":"2019","unstructured":"Bejarano L, Bosso G, Louzame J, Serrano R, G\u00f3mez-Casero E, Mart\u00ednez-Torrecuadrada J, et al. Multiple cancer pathways regulate telomere protection. EMBO Mol Med. 2019;11:1\u201321.","journal-title":"EMBO Mol Med"},{"key":"4597_CR63","doi-asserted-by":"publisher","unstructured":"Bosso G, Cipressa F, Moroni ML, Pennisi R, Albanesi J, Brandi V, et al. NBS1 interacts with HP1 to ensure genome integrity. Cell Death Dis. 2019;10. Available from: https:\/\/doi.org\/10.1038\/s41419-019-2185-x","DOI":"10.1038\/s41419-019-2185-x"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04597-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04597-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04597-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:07:26Z","timestamp":1669302446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04597-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["4597"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-04597-z","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"assertion":[{"value":"27 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors approved and directly participated in the planning and\/or execution of the experiments and\/or analysis of the data presented herein. The animal studies were conducted in accordance with the Animal Use Protocol approved by theInstitutional Animal Care and Use Committee (IACUC) and by the Ethical Committee for animal experimentation (CEIyBA) (PROEX 106.7\/20).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All authors have provided their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"142"}}